BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
0.9400
-0.0337 (-3.46%)
At close: Aug 17, 2026, 4:00 PM EDT
0.91951
-0.0205 (-2.18%)
After-hours: Aug 17, 2026, 7:10 PM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $10.69 million as of August 17, 2026. Its market cap has decreased by -4.01% in one year.
Market Cap
10.69M
Enterprise Value
6.87M
1-Year Change
-4.01%
Ranking
Category
Stock Price
$0.94
ChartMarket Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $10.69M, a decrease of -63.22%. That is a compound annual growth rate of -9.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 10.69M | -19.40% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 11.46M |
| IN8bio | 10.94M |
| Instinct Bio Technical Company Holdings | 10.92M |
| Theriva Biologics | 10.90M |
| CytoMed Therapeutics | 10.72M |
| Adial Pharmaceuticals | 10.70M |
| Vistagen Therapeutics | 10.67M |
| Quoin Pharmaceuticals | 10.42M |